Literature DB >> 24436571

Gynecologic biopsy for molecular profiling: a review for the interventional radiologist.

Bradley R Corr1, Kian Behbakht1, Monique A Spillman1.   

Abstract

The interventional radiologist is often asked to obtain multiple biopsies of gynecological malignancies for genetic profiling. This article reviews the current indications for gynecological biopsy as well as how the information gained contributes to a personalized medicine plan for the individual patient. The specific focus of this review is the current knowledge and practice of molecular profiling for gynecological malignancies.

Entities:  

Keywords:  biopsy; genetic profiling; gynecological cancer; interventional radiology; molecular profiling

Year:  2013        PMID： 24436571      PMCID： PMC3835589          DOI： 10.1055/s-0033-1359738

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  37 in total

Review 1.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Authors:  Dimitrios Spentzos; Douglas A Levine; Marco F Ramoni; Marie Joseph; Xuesong Gu; Jeff Boyd; Towia A Libermann; Stephen A Cannistra
Journal:  J Clin Oncol       Date:  2004-10-25       Impact factor: 44.544

Review 3.  Molecular characterization of ovarian cancer by gene-expression profiling.

Authors:  C Gómez-Raposo; M Mendiola; J Barriuso; D Hardisson; A Redondo
Journal:  Gynecol Oncol       Date:  2010-05-01       Impact factor: 5.482

Review 4.  Human papillomavirus infection: biology, epidemiology, and prevention.

Authors:  M E Scheurer; G Tortolero-Luna; K Adler-Storthz
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

5.  Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.

Authors:  Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

6.  An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

Authors:  Holly K Dressman; Andrew Berchuck; Gina Chan; Jun Zhai; Andrea Bild; Robyn Sayer; Janiel Cragun; Jennifer Clarke; Regina S Whitaker; Lihua Li; Jonathan Gray; Jeffrey Marks; Geoffrey S Ginsburg; Anil Potti; Mike West; Joseph R Nevins; Johnathan M Lancaster
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

Review 7.  Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation.

Authors:  Takashi Koyama; Yoshiki Mikami; Tsuneo Saga; Ken Tamai; Kaori Togashi
Journal:  Abdom Imaging       Date:  2007-02-21

8.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

Review 9.  From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.

Authors:  Robert H Young
Journal:  Adv Anat Pathol       Date:  2007-05       Impact factor: 3.875

10.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Authors:  C P Morrow; B N Bundy; R J Kurman; W T Creasman; P Heller; H D Homesley; J E Graham
Journal:  Gynecol Oncol       Date:  1991-01       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.